QuotedData

Quoted Data

sign up for emailed equity research
Quick  |   Customised Register
Latest News

Biotech and Healthcare News

Biotech Growth sells Amgen, buys Regeneron and Alexion in March

Biotech Growth sells Amgen, buys Regeneron and Alexion in March

Biotech Growth sells Amgen, buys Regeneron and Alexion in March OrbiMed-managed Biotech Growth Trust (BIOG) sold a large proportion of its stake in Amgen last month, while increasing its holdings in ...

MedicX acquires a new primary healthcare medical centre in Peterborough

MedicX acquires a new primary healthcare medical centre in Peterborough

MedicX acquires a new primary healthcare medical centre in Peterborough MedicX (MXF) has contracted to acquire a new primary healthcare medical centre in Peterborough. The property is due to be completed ...

WWH's hedging of Merck-BMS data comp backfires

WWH’s hedging of Merck-BMS data comp backfires

WWH's hedging of Merck-BMS data comp backfires Worldwide Healthcare Trust's (WWH) apparent attempt to hedge its bet on the outcome of the three trials of anti-pd(L)-1 checkpoint inhibitors in first-line treatment of ...

Shire move leaves BB Healthcare stake in limbo

Shire move leaves BB Healthcare stake in limbo

Shire disposal leaves BB Healthcare stake in limbo Shire Pharmaceuticals' announcement this morning of an agreement to sell its oncology business to Servier for $2.4bn in cash, leaves the stake in ...

BG-backed Orchard buys GSK rare disease portfolio

BG-backed Orchard buys GSK rare disease portfolio

BG-backed Orchard buys GSK rare disease portfolio Baillie Gifford-backed gene therapy company Orchard Therapeutics has acquired GlaxoSmithKline's portfolio of investigational and approved rare disease gene therapies in exchange for a 19.9% equity ...

Worldwide Health offers a way to play AACR lung data reveal

Worldwide Health offers a way to play AACR lung data reveal

Worldwide Health offers a way to play AACR lung data reveal London-listed Worldwide Healthcare Trust (WWH) could be best way for trust investors to obtain exposure to what is likely to be the most ...

BB Biotech may have to take hit on Incyte stake

BB Biotech may have to take hit on Incyte stake

BB Biotech may have to take hit on Incyte stake Switzerland’s BB Biotech (BBB.S) looks set to be in for a difficult month in terms of performance as a result of ...

Syncona sees slight dip in NAV as Nightstar declines

Syncona sees slight dip in NAV as Nightstar declines

Syncona sees slight dip in NAV as Nightstar declines UK hybrid biotech investor/fund-of-funds Syncona (SYNC) saw a 0.8% fall in its NAV in February according to its latest factsheet, principally as a result ...

HBM Healthcare to benefit from Homology Medicines IPO

HBM Healthcare to benefit from Homology Medicines IPO

HBM Healthcare to benefit from Homology Medicines IPO Swiss-listed HBM Healthcare (HBMN) is set to receive a modest boost to its NAV following the US initial public offering last week of Homology Medicines (Nasdaq: ...

WPCT gets surprise boost up trust leaguetable from Prothena deal

WPCT gets surprise boost up trust leaguetable from Prothena deal

WPCT gets surprise boost up trust leaguetable from Prothena deal An unexpected recovery in Woodford Patient Capital Trust (WPCT)'s share price last month on the back of the collaboration signed between ...

Contact us

captcha